Search
Cancer Mission
This page gathers all EACS work related to Horizon Europe Cancer Mission and Europe’s Beating Cancer plan.
Building on the collective work from its members, the EACS and several European Organisations and cancer centers joined forces to define common goals for the implementation of a mission-oriented approach to cancer in Horizon Europe.
In July 2020, « Towards a cancer mission in Horizon Europe: recommendations » provided a detailed view of the infrastructural requirements to promote high-quality translational research, clinical and prevention trials and outcomes research, ensuring that science-driven and social innovations benefit patients and individual at risk across the healthcare system in the European Union. The document also emphasizes consensus priority research areas to realise the cancer mission objectives and outlines recommendations for actively engaging citizens, patients, professionals, and institutions throughout Europe. Details of each recommendation can be found below.
Long-term support by the EU and commitment of Member States to specialised schemes are also needed for the establishment and sustainability of trans-border infrastructures and networks. EACS looks to actively and effectively engaging with policy-makers and all the relevant stakeholders along the entire research–care–prevention continuum to inform policy through evidence-based advice. EACS actively participated and supported the work of the trio Presidency of the Council of the European Union - Germany, Portugal and Slovenia (July 2020 to December 2021) in their collective policy work on cancer, leading to the « Declaration on effective cancer research » (October 2020) and to the « Porto Declaration on cancer research » (May 2021). Both documents pave the way to a comprehensive translational cancer research approach focused on personalized and precision medicine, and covering the entire cancer research– care–prevention continuum . This approach has the potential to achieve in 2030 a 10-year cancer-specific survival for 75% of patients diagnosed in European Union (EU) member states with a well-developed healthcare system.
Infrastructures to support cancer research of excellence.
EACS proposed the establishment of three types of infrastructures focusing on translational research, ...
Basic & preclinical research
To better understand the molecular mechanisms underlying cancer in order to fuel innovation in ...
Primary prevention
To address regulatory, political and societal barriers that hamper its implementation and achieve ...
Early detection
To identify early markers that predict progression to malignant disease and be able ...
Development of new therapies
EACS recommendations for development of new therapies can be summarized as follows: Increase support ...
Psychosocial oncology, rehabilitation, & survivorship research
For these three research areas our recommendations are: Support methodological development for assessment of ...
Palliative oncology
To support care and accommodate patients’ needs along their cancer journey, our recommendations ...
Paediatric oncology
Given childhood cancers’ unique set of challenges and existing successful cross-border, multidisciplinary and ...
Geriatric oncology
To better understand the relationship between aging and cancer we recommend to: Support basic ...
Outcomes research
Different domains of cancer need definition of distinct outcomes parameters as no outcome ...
Health economics
Health economics needs to be included as an integral component of the translational ...
Big data and computational science
EU-wide population databases will be indispensable for answering some key scientific questions raised ...
Patient empowerment
To improve the healthcare systems while addressing unmet needs, patient empowerment should focus ...
Specialist education
Education must cover all components of the cancer research/care/prevention continuum and be accessible ...
Addressing inequalities in cancer research
Increasing quality and quantity of research capacities across Europe is needed to address ...